Dragon Stilbene Ann Vein Capsule Clinical Research For The Treatment Of Qi Andblood Deficiency Type Of Ventricular Premature Beat

Objective: To observe the Dragon stilbene Ann vein capsules on the clinical curative effect and security of the treatment of qi and blood deficiency type of ventricular premature beat; lay a foundation for clinical application.Methods: From shangqiu hospital heart medicine wards, and the clinic screening from March 2013 to March 2014 of 50 cases,western medicine diagnosis of arrhythmia of ventricular premature beat,the diagnosis of traditional Chinese medicine is heart palpitations both qi and blood deficiency syndrome. According to the principle of randomized, controlled will be divided into the treatment group and control group(n = 25),the treatment group(11 male, female 14 cases, age distribution at the age of 40 to 76 years old, the average age was 58±10.73); The control group(male 12 cases, 13 cases of female, age distribution in 38 to 75 years, the average age was 58±9.82). Two groups of patients in early times, sex, age, room early classification, disease classification of syndromes, etc under the condition of no statistical difference.The control group conventional oral “rhythm of the heart flat piece”;The treatment group on the basis of control group,adding “dragon stilbene vein capsule, three times a day, four at a time, 4 weeks as a course of treatment”. To observe before and after treatment between two groups in the lower chamber early, alleviate symptoms of TCM,and other aspects of the data. Objectiving evaluation the dragon stilbene Ann vein capsule in the treatment of qi and blood deficiency type of ventricular premature beat safety usage and curative effect. This clinical research adopts Beijing American probe software company production models with the dynamic ecg analyzer for MGY- H12 24 h continuous recording. Data analysis by SPSS Statistics 17.0 to P < 0.05 for the difference was statistically significant.Results:(1) Comparing two groups before and after treatment to reduce number of ventricular premature beat: The treatment group before and after the room number: 1663±703、743±331; The control group before and after the room number: 1662±714、1146±316.By t test, the treatment group and control group comparison between before and after treatment groups,t = 6.667,P = 0.000 < 0.05, the difference was statistically significant, the treatment group was better.(2) The main symptoms of TCM palpitations, shortness of breath, chest tightness of curative effect comparison: The treatment group total efficiency, respectively 68%、72%、76%,The total effective rate is 96%;The control group the total efficiency, respectively 44%、48%、44%,The total effective rate, respectively 84%、84%、86%.Checked by Fisher’s exact probability method, P=0.010<0.05, the difference was statistically significant.(3) Security comparisons:1) The blood routine, urine routine, stool routine, and hepatic and renal function examination: two groups of urine routine, stool routine results showed negative;In the two groups before and after their routine blood, liver, kidney function, by t test, P > 0.05, there was no statistically significant difference; 2) Comparing two groups of adverse reaction extent, by the X2 test, P > 0.05, there was no statistically significant difference, relatively safe drug.Conclusion: Dragon stilbene Ann joint vein capsule treat qi and blood deficiency type of ventricular premature beat, compared with the pure rhythm of the heart flat piece of treatment,In reducing the number of premature ventricular, relieving the clinical symptoms,and drug safety more advantages,and its easy to carry, safe and effective, price moderate, is worth popularizing in clinical application.